SCHEMBL4053018

SCHEMBL4053018

Cc1cn2nc(Cl)ccc2n1.Cc1nc2ccc(Cl)nn2c1Br

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.41
COMT P21964 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
AHR P35869 4/20 0.35
DRD2 P14416 4/20 0.34
DRD4 P21917 4/20 0.34
DRD3 P35462 4/20 0.34
HTR1A P08908 3/20 0.34
ADRA1D P25100 3/20 0.34
ADRA1A P35348 3/20 0.34
ADRA1B P35368 3/20 0.34
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
TNF P01375 1/20 0.33
PDE10A Q9Y233 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4052890 0.88 KDM4E (0.44) DYRK1AKDM4EALDH1A1SMN1; SMN2PRMT5
Bromide SCHEMBL7381867 0.86 KDM4E (0.43) DYRK1AKDM4EALDH1A1SMN1; SMN2PRMT5
Bromide SCHEMBL7381858 0.86 KDM4E (0.43) DYRK1AKDM4EALDH1A1SMN1; SMN2PRMT5
Bromide SCHEMBL10399879 0.86 KDM4E (0.43) DYRK1AKDM4EALDH1A1SMN1; SMN2PRMT5
SCHEMBL477109 0.84 DYRK1A (0.53) DYRK1ACOMTKDM4EALDH1A1SMN1; SMN2
SCHEMBL23748001 0.72 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2AHRPDE10A
SCHEMBL477062 0.72 KDM4E (0.44) DYRK1AKDM4EALDH1A1SMN1; SMN2PRMT5
SCHEMBL29020764 0.71 DYRK1A (0.53) DYRK1ACOMTKDM4EALDH1A1SMN1; SMN2
SCHEMBL3357291 0.71 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2AHRDRD2
SCHEMBL12798307 0.71 KDM4E (0.47) KDM4EALDH1A1SMN1; SMN2PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079744-A1 IMIDAZOPYRIDAZINES AS PI3K LIPID KINASE INHIBITORS Novartis AG (CH) 2009-07-22 EP disclosed
WO-2008052733-A1 IMIDAZOPYRIDAZINES AS PI3K LIPID KINASE INHIBITORS NOVARTIS AG (CH) 2008-05-08 WO disclosed